“With two new FDA-approved therapies now available to treat idiopathic pulmonary fibrosis, timely and accurate diagnosis has become critical in the early management of patients with IPF.” - Dr. David Lederer
Boston, MA (PRWEB) October 23, 2015
Pulmonologists, respiratory therapists, internists, primary care physicians, advanced practice nurses, physician assistants and other clinicians who care for patients with IPF will have an opportunity to hear experts discuss the evolution of treatment for patients with Idiopathic Pulmonary Fibrosis live via online video at no cost at RESInsightsLive. The event will be held on October 27, 2015, at 12:00 AM PT at http://www.RESInsightsLive.com.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and PlatformQ Health Education, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The program will feature Fernando J. Martinez, MD, MS, Weill Cornell Medical College and David J. Lederer, MD, MS, Columbia University Medical Center. Topics in the hour-long program will include: Advances in defining pathologic features and molecular pathways that are activated in IPF; Hallmark signs and symptoms of IPF; Key diagnostic methods for definitive diagnosis of IPF; Potential targets of the IPF disease process that can be leveraged for drug development; and New antifibrotic drugs that extend survival and improve quality of life. This activity is supported by PlatformQ Health Education, LLC.
RESInsightsLive offers an effective way for pulmonologists, respiratory therapists, internists, primary care physicians, and others to easily stay current on advances in care without leaving their office. There is no cost to register and watch any educational session at RESInsightsLive. Clinicians who attend live may take advantage of interactive capabilities like submitting questions to be addressed live online by presenting faculty and interactive polling.
To learn more and register at no cost for this live interactive video webcast, visit http://www.RESInsightsLive.com
RESInsightsLive is a leader in online CME programs in pulmonary treatment and science produced by PlatformQ Health, Inc. RESInsightsLive enables pulmonologists, respiratory therapists, internists, primary care physicians, and others to learn, connect, and interact in real time. RESInsightsLive offers virtual medical education at no cost and delivers all the benefits of a physical conference, with live presentations, real-time interactive Q&A, and an exhibit floor, all from the convenience of a computer. To learn more about RESInsightsLive, follow us via Twitter at @RESInsightsLive.